title: Urinary and rectal incontinence during gabapentin therapy.
authors.forename: Renuka
authors.initials: R
authors.lastname: Iyer
authors.forename: Lori
authors.initials: L
authors.lastname: Egloff
authors.forename: Jamie
authors.initials: J
authors.lastname: Fraas
authors.forename: Juan-Diego
authors.initials: JD
authors.lastname: Harris
mesh_terms: D000368:Aged; D000588:Amines / Q000009:adverse effects* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D005242:Fecal Incontinence / Q000139:chemically induced*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D014549:Urinary Incontinence / Q000139:chemically induced*; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin